Opioid-induced bowel dysfunction: pathophysiology and management.
about
Evolving paradigms in the treatment of opioid-induced bowel dysfunctionThe Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionThe role of naloxegol in the management of opioid-induced bowel dysfunctionAcetylcholine serves as a derepressor in Loperamide-induced Opioid-Induced Bowel Dysfunction (OIBD) in zebrafishAdvances in pharmacotherapy for opioid-induced constipation - a systematic review.Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trialsThe colon: from banal to brilliant.Strategies for preventing side effects of systemic opioid in postoperative pediatric patients.Treatment of failed back surgery syndrome in a forty-three-year-old man with high-dose oxycodone/naloxone.Efficacy and safety of naloxegol in patients with opioid-induced constipation and laxative-inadequate responseDivergent Effect of Dezocine, Morphine and Sufentanil on Intestinal Motor Function in Rats.Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomesThe Impact of Opioid Treatment on Regional Gastrointestinal Transit.Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanylComparison of effects of epidural bupivacaine and intravenous meperidine analgesia on patient recovery following elective abdominal aortic surgeryImpact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced ConstipationPharmacological pain management in chronic pancreatitis.Pharmacological challenges in chronic pancreatitis.6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand.Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment.Oxycodone combined with opioid receptor antagonists: efficacy and safety.Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.Pain and chronic pancreatitis: a complex interplay of multiple mechanisms.Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.Naloxegol for the treatment of opioid-induced constipation.Naloxegol , a new drug for the treatment of opioid-induced constipation.Naloxegol: a review of its use in patients with opioid-induced constipation.Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation.Management of chronic visceral pain.Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline.Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.How Do Hospital Palliative Care Teams Use the WHO Guidelines to Manage Unrelieved Cancer Pain? A 1-Year, Multicenter Audit in Japan.The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.Reproducibility of psychophysics and electroencephalography during offset analgesia.The place of oxycodone/naloxone in chronic pain management.Medical influences, surgical outcomes: role of common medications on the risk of perforation from untreated diverticular disease.
P2860
Q26777692-B3BD4E8E-ED64-4973-8A4E-AE512478F475Q26851158-1B3A1398-ABF8-46E4-A0A0-C8F08B88FD97Q26995944-E04955AC-791C-49DF-A583-CFCEBC469508Q27010907-A7051812-C5A6-415D-A952-FB23DC5E9D66Q28072039-D45CC133-E5E1-405E-BB29-0F30520E7FBCQ30582847-DF73D373-F7C4-415A-90AA-698365AB3D59Q34455604-144E774F-869D-4292-AB80-CA6E5BC78600Q34693351-3F50D8C3-986E-4BF4-A69D-B3DA924F937CQ35017883-DA6A497C-1A87-47F1-8ACF-DDEFAACDAFBBQ35165336-83BA80EB-841E-4F5B-BEDD-6C946AF685DDQ35226014-014A13B3-A5FF-4A1D-9414-B485861E4604Q36223541-08690E37-3C08-4A30-9CD5-7E1AB3E975F6Q36274984-B30E113D-14D2-4FDD-9534-B2BCF98BB0E5Q36696556-0177CFE3-FB20-433D-BA96-DC68C00CE221Q36762661-B238653A-81CE-4DA3-A5E7-9AC8AB1B3199Q36780862-4CCD77B8-E929-494A-BBB0-5A144D3BF550Q36859336-DB4CB8FB-0590-4D88-AC34-8FB68BF2E24EQ37143758-C12A9B8E-357A-47FC-A61B-3C45D86E7FF8Q37233788-23420FA7-0E69-47AB-B8EA-F103E3B06C0BQ37317433-9C56D31E-0729-492F-A90F-1F76CA040FF3Q37317436-94BA5350-3576-4AEF-8707-F721235FB21BQ37444418-0387E04C-6898-417F-B8D4-BDF06589501AQ37491434-0FF798F5-DB44-4AFB-A36B-5ABABE02384DQ37562469-2284C01D-4C9D-4A51-A2E6-C1F4E38FDEECQ38093671-79848697-D2E4-46EF-AA64-7CA8942306BEQ38123753-B8EFB864-6A85-4D91-B5A4-11E3FC0F134AQ38164701-91677F78-0126-411E-8A6E-E121CC5E886EQ38181019-2EB82931-396B-42EA-AD8D-8A815F684557Q38249098-D529FB24-92DC-4165-9D85-E15EC82FD195Q38286331-F866FCF7-2B52-42B9-BA3A-99CA6685383CQ38349821-2EC39393-9F9B-49FC-B265-D9362986B95EQ38800701-50D894B3-C886-4AFC-9C46-29FA7D105DA6Q38852271-A66DA0DF-8286-4258-B61D-EA4961C05AEDQ39051851-E7C8C48A-CDB7-48AE-A4BD-9CD2FCCFD8AAQ39151428-F1D0A972-1F51-47C6-AD70-596A511EDBEBQ39182361-C6787A4C-8021-42A4-85E6-6C5BFD7990C3Q39229690-A87076A6-72F9-473B-A324-D53F9D9733DAQ39311623-2601DFAD-9394-4A09-A7C9-747AEE64703AQ42161578-1D494085-D1E6-4A2F-8579-AD4C3E6798F0Q42965102-4A1CE0B0-236A-459F-BC74-01304E1D40A7
P2860
Opioid-induced bowel dysfunction: pathophysiology and management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Opioid-induced bowel dysfunction: pathophysiology and management.
@en
type
label
Opioid-induced bowel dysfunction: pathophysiology and management.
@en
prefLabel
Opioid-induced bowel dysfunction: pathophysiology and management.
@en
P2860
P50
P1433
P1476
Opioid-induced bowel dysfunction: pathophysiology and management.
@en
P2093
Jens Brøndum Frøkjaer
Trine Andresen
P2860
P304
P356
10.2165/11634970-000000000-00000
P577
2012-10-01T00:00:00Z
P6179
1023336846